Olek Elizabeth A
SR VP, CLINICAL SCIENCE at Kronos Bio, Inc.; SVP and CMO at ACHILLION PHARMACEUTICALS INC
- Sold, on record
- $133k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Feb 21, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Kronos Bio, Inc.SR VP, CLINICAL SCIENCE
- ACHILLION PHARMACEUTICALS INCSVP and CMO
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Sales by company
- ACHILLION PHARMACEUTICALS INC12,468 shares
- Kronos Bio, Inc.7,368 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ACHILLION PHARMACEUTICALS INCUnusualJan 10, 2012 2012
Sold 12,468 shares at $10.06 ($125k)
Olek Elizabeth A, SVP and CMO
Sold 86.2% of holdings ($146k position)2,000 shares leftFirst sale on recordFiling
- 2 Form 4 sale Kronos Bio, Inc.No planFeb 21, 2024 +4425 days
Sold 7,368 shares at $1.05 ($8k)
Olek Elizabeth A, SR VP, CLINICAL SCIENCE
No 10b5-1 planSold 3.7% of holdings ($211k position)193,275 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | Feb 23, 2024 | Kronos Bio, Inc. | SR VP, CLINICAL SCIENCE | Form 4 sale | 7,368 | $8k | 3.7% | No plan | SEC |
| Jan 10, 2012 | Jan 11, 2012 | ACHILLION PHARMACEUTICALS INC | SVP and CMO | Form 4 sale | 12,468 | $125k | 86.2% | Unusual | SEC |